Persongen Biotherapeutics (suzhou) Co., Ltd.

This is an early safety study testing a new CAR-T cell therapy called LV009 for adults with certain blood cancers (like non-Hodgkin lymphoma or acute lymphoblastic leukemia) that have come back or not responded to other treatments. The main goals are to find a safe dose and see h…

This study is testing an experimental treatment called PA3-17, a type of CAR-T cell therapy, for adults whose T-cell leukemia or lymphoma has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better targe…

This early study is testing a new cell therapy called UTAA07 in adults with advanced blood cancers that have returned or not responded to other treatments. The main goals are to check the safety of the treatment and find the best dose for future studies. Researchers will also get…

This early-phase study is testing the safety of an experimental cell therapy called LV009 injection. It is for adults whose CD19-positive blood cancers, like non-Hodgkin lymphoma or acute lymphoblastic leukemia, have returned or not responded to other treatments. The main goal is…